The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jin, S.-L. C.
Right arrow Articles by Conti, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jin, S.-L. C.
Right arrow Articles by Conti, M.
The Journal of Immunology, 2005, 175: 1523-1531.
Copyright © 2005 by The American Association of Immunologists

Specific Role of Phosphodiesterase 4B in Lipopolysaccharide-Induced Signaling in Mouse Macrophages 1

S.-L. Catherine Jin, Linda Lan, Maria Zoudilova and Marco Conti2

Division of Reproductive Biology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA 94305

Cyclic nucleotide signaling functions as a negative modulator of inflammatory cell responses, and type 4 phosphodiesterases (PDE4) are important regulators of this pathway. In this study, we provide evidence that only one of the three PDE4 genes expressed in mouse peritoneal macrophages is involved in the control of TLR signaling. In these cells, LPS stimulation of TLR caused a major up-regulation of PDE4B but not the paralogs PDE4A or PDE4D. Only ablation of PDE4B impacted LPS signaling and TNF-{alpha} production. TNF-{alpha} mRNA and protein were decreased by >50% in PDE4B–/–, but not in PDE4A–/– or PDE4D–/– macrophages. The PDE4 selective inhibitors rolipram and roflumilast had no additional inhibitory effect in macrophages deficient in PDE4B, but suppressed the TNF-{alpha} response in the other PDE4 null cells. The inhibition of TNF-{alpha} production that follows either genetic ablation or acute inhibition of PDE4B is cAMP-dependent and requires protein kinase A activity. However, no global changes in cAMP concentration were observed in the PDE4B–/– macrophages. Moreover, ablation of PDE4B protected mice from LPS-induced shock, suggesting that altered TLR signaling is retained in vivo. These findings demonstrate the highly specialized function of PDE4B in macrophages and its critical role in LPS signaling. Moreover, they provide proof of concept that a PDE4 inhibitor with subtype selectivity retains useful pharmacological effects.




This article has been cited by other articles:


Home page
 EndocrinologyHome page
R. Zhang, E. Maratos-Flier, and J. S. Flier
Reduced Adiposity and High-Fat Diet-Induced Adipose Inflammation in Mice Deficient for Phosphodiesterase 4B
Endocrinology, July 1, 2009; 150(7): 3076 - 3082.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
X. Li, G. S. Baillie, and M. D. Houslay
Mdm2 Directs the Ubiquitination of {beta}-Arrestin-sequestered cAMP Phosphodiesterase-4D5
J. Biol. Chem., June 12, 2009; 284(24): 16170 - 16182.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Mogi, M. Tobo, H. Tomura, N. Murata, X.-d. He, K. Sato, T. Kimura, T. Ishizuka, T. Sasaki, T. Sato, et al.
Involvement of Proton-Sensing TDAG8 in Extracellular Acidification-Induced Inhibition of Proinflammatory Cytokine Production in Peritoneal Macrophages
J. Immunol., March 1, 2009; 182(5): 3243 - 3251.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. R. Raymond, R. L. Carter, C. A. Ward, and D. H. Maurice
Distinct phosphodiesterase-4D variants integrate into protein kinase A-based signaling complexes in cardiac and vascular myocytes
Am J Physiol Heart Circ Physiol, February 1, 2009; 296(2): H263 - H271.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. Goldhoff, N. M. Warrington, D. D. Limbrick Jr., A. Hope, B. M. Woerner, E. Jackson, A. Perry, D. Piwnica-Worms, and J. B. Rubin
Targeted Inhibition of Cyclic AMP Phosphodiesterase-4 Promotes Brain Tumor Regression
Clin. Cancer Res., December 1, 2008; 14(23): 7717 - 7725.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
L. Gobejishvili, S. Barve, S. Joshi-Barve, and C. McClain
Enhanced PDE4B expression augments LPS-inducible TNF expression in ethanol-primed monocytes: relevance to alcoholic liver disease
Am J Physiol Gastrointest Liver Physiol, October 1, 2008; 295(4): G718 - G724.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. D. Bruss, W. Richter, K. Horner, S.-L. C. Jin, and M. Conti
Critical Role of PDE4D in {beta}2-Adrenoceptor-dependent cAMP Signaling in Mouse Embryonic Fibroblasts
J. Biol. Chem., August 15, 2008; 283(33): 22430 - 22442.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Herve, T. Schmitz, D. Evain-Brion, D. Cabrol, M.-J. Leroy, and C. Mehats
The PDE4 Inhibitor Rolipram Prevents NF-{kappa}B Binding Activity and Proinflammatory Cytokine Release in Human Chorionic Cells
J. Immunol., August 1, 2008; 181(3): 2196 - 2202.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
Y.-F. Cheung, Z. Kan, P. Garrett-Engele, I. Gall, H. Murdoch, G. S. Baillie, L. M. Camargo, J. M. Johnson, M. D. Houslay, and J. C. Castle
PDE4B5, a Novel, Super-Short, Brain-Specific cAMP Phosphodiesterase-4 Variant Whose Isoform-Specifying N-Terminal Region Is Identical to That of cAMP Phosphodiesterase-4D6 (PDE4D6)
J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 600 - 609.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Peter, S. L. C. Jin, M. Conti, A. Hatzelmann, and C. Zitt
Differential Expression and Function of Phosphodiesterase 4 (PDE4) Subtypes in Human Primary CD4+ T Cells: Predominant Role of PDE4D
J. Immunol., April 15, 2007; 178(8): 4820 - 4831.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
M. D. Houslay, G. S. Baillie, and D. H. Maurice
cAMP-Specific Phosphodiesterase-4 Enzymes in the Cardiovascular System: A Molecular Toolbox for Generating Compartmentalized cAMP Signaling
Circ. Res., April 13, 2007; 100(7): 950 - 966.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
K. Omori and J. Kotera
Overview of PDEs and Their Regulation
Circ. Res., February 16, 2007; 100(3): 309 - 327.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Schmitz, E. Souil, R. Herve, C. Nicco, F. Batteux, G. Germain, D. Cabrol, D. Evain-Brion, M.-J. Leroy, and C. Mehats
PDE4 Inhibition Prevents Preterm Delivery Induced by an Intrauterine Inflammation
J. Immunol., January 15, 2007; 178(2): 1115 - 1121.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
J. Cheng and J. P. Grande
Cyclic Nucleotide Phosphodiesterase (PDE) Inhibitors: Novel Therapeutic Agents for Progressive Renal Disease
Experimental Biology and Medicine, January 1, 2007; 232(1): 38 - 51.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
K. McCluskie, U. Klein, C. Linnevers, Y.-h. Ji, A. Yang, C. Husfeld, and G. R. Thomas
Phosphodiesterase Type 4 Inhibitors Cause Proinflammatory Effects in Vivo
J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 468 - 476.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
A. T. Bender and J. A. Beavo
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use
Pharmacol. Rev., September 1, 2006; 58(3): 488 - 520.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.